发明名称 SYNTHETIC INTERMEDIATE
摘要 <P>PROBLEM TO BE SOLVED: To provide a novel nucleoside compound for treatment of a host infected with a hepatitis C virus; and to provide a pharmaceutical composition containing the compound. <P>SOLUTION: There are provided a nucleoside of formula (1) or a salt added with an acid thereof, and a pharmaceutical composition containing the compound. In the formula, R<SP POS="POST">1</SP>and R<SP POS="POST">3</SP>are each hydrogen; R<SP POS="POST">2</SP>is a monophosphate ester, diphosphate ester, triphosphate ester or the like; R<SP POS="POST">4</SP>is alkyl or the like; R<SP POS="POST">5</SP>is hydrogen, alkyl or the like; and R<SP POS="POST">6</SP>is hydrogen or alkoxy. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2011246485(A) 申请公布日期 2011.12.08
申请号 JP20110167159 申请日期 2011.07.29
申请人 MEDIVIR AB 发明人 JOHANSSON NILS-GUNNAR;KALAYANOV GENADIY;MARTIN JOSEPH ARMSTRONG;SMITH DAVID BERNARD;WINQVIST ANNA
分类号 C07H19/06;A61K31/7068;A61K38/21;A61K38/22;A61K45/00;A61P1/16;A61P31/14;A61P43/00 主分类号 C07H19/06
代理机构 代理人
主权项
地址